Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by narmacon Apr 13, 2022 11:27am
114 Views
Post# 34600470

RE:RE:RE:RE:RE:RE:Congratulations to Dr. Rathjen

RE:RE:RE:RE:RE:RE:Congratulations to Dr. Rathjen,,,anyone with an educated guess as to us&partner or one of our clients submitting an IND this year?,,,what might give us a clue or is there substantial lab work left for such a move. Or is all still a vast unknown?,,,,What about the lost/ corruted data that we incurred during transport of the lab work? ,,,,should we not expect a major development this year?,,,we must be nearing a reflection point where our true position around this science is realized. 
Do we need to be one step away from commercializing an xB3 program combo drug before share price might respond with a large positive move?,,,,I say we just need to progress in clear positive steps for the market to evaluate what the potential down the road is. Jmo.

,,cuzzz,,,,,its going to be,,,BTI to duuuhhhhh mooooon!!,,,and could it be $18 in 24 or even more?????,,,,,,the sky is our limit....have no doubt about it,,,,,,,
<< Previous
Bullboard Posts
Next >>